Medical Health Encyclopedia

Computerized Pap Test Systems

New tests and methods have been developed to improve the accuracy of the Pap smear in detecting cancer cells. For example, there are several computerized Pap test systems (FocalPoint, PAPNET) that are used to rescreen the original smear. These systems are either used to detect abnormal samples that may have been missed by manual review methods or are used in place of a human cytotechnologist. According to the US Preventive Services Task Force (USPSTF), there is not yet enough evidence to know whether or not computerized methods are superior to conventional Pap testing.

Tests for Human Papilloma Virus (HPV)

The high-risk types of human papilloma virus (HPV) are now a known cause of cervical cancer. Tests are now available for identifying these types. Their presence is a strong predictor of high-grade aggressive abnormalities or cancer itself. Testing for HPV does not replace the Pap smear, but when used adjunctively with the Pap test this screening combination may help to more accurately detect cervical cell abnormalities than either test alone.

In 2003, the FDA approved the Hybrid Capture 2 (HC2) HPV DNA test for use with the Pap test for cervical cancer screening in women over 30 years of age. The HPV DNA test can identify 13 types of the high-risk HPV that are most frequently implicated in the development of cervical cancer. At this time, the test is recommended as an adjunct to the Pap test but not as the sole method for primary screening.

Other Screening Tests

Text Continues Below

---

Other screening tests are being investigated for use in combination with the Pap smear for improving accuracy. For example, combinations with HPV DNA tests or cervicography may prove to be more effective for detecting CIN II and III dysplasia (potentially invasive cells) than Pap smears alone.